N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study-Reference-Cited by-同舟云学术

N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

Published:2022-10 Issue:10 Volume:28 Page:1391.e1-1391.e5
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Almansa Raquel,Eiros Jose María,de Gonzalo-Calvo David,Postigo Tamara,Ortega Alicia,Lopez-Izquierdo Raul,Moncusí-Moix Anna,Gort-Paniello Clara,Dominguez-Gil Marta,de la Fuente Amanda,González-González Laura,Luis-García Tania,García-Mateo Nadia,Tedim Ana P.,Rodríguez-Jara Fátima,Jorge Noelia,González Jessica,Torres Gerard,Gutiérrez-Pérez Oliver Norberto,Villegas Maria José,Campo Sonia,Ayllon Eva,Ruiz Albi Tomás,de Frutos Arribas Julio,Arroyo Domingo Ainhoa,Abadia-Otero Jesica,Gómez Barquero Julia,Trapiello Wysali,Garcia Frade Luis Javier,Inglada Luis,del Campo Felix,Bermejo-Martin Jesús F.,Barbé Ferran,Torres Antoni

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Risk factors of viral RNAaemia and its association with clinical prognosis among patients with severe COVID-19;Li;Chest,2021

2. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19;Bermejo-Martin;Crit Care,2020

3. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with Coronavirus Disease 2019;Tang;J Med Virol,2021

4. Therapeutic implications of ongoing alveolar viral replication in COVID-19;McGonagle;Lancet Rheumatol,2022

5. COVID 19: a clue from innate immunity;Birra;Immunol Res,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to comment on ‘Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study’;Human Vaccines & Immunotherapeutics;2024-09-05

2. SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir;The Journal of Infectious Diseases;2024-04-24

3. Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19;International Journal of Infectious Diseases;2024-03

4. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study;The Lancet Microbe;2023-06

5. Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19;Critical Care;2022-09-14